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Virus-like particles (VLPs) constitute a promising platform in vaccine development and targeted drug-delivery. 
However, most applications use simple, non-enveloped VLPs that present less technical challenges, not only to 
produce and purify, but also in terms of characterization, compared to enveloped VLPs. 
Recent advances in upstream processing, new product quality requirements and other regulatory issues, as well 
as the search for more cost-effective processes, led to the need to develop more efficient downstream 
processes for biopharmaceuticals.[1]  In that sense, new monitoring and product characterization methods, which 
can be applied at all stages of downstream processing, are needed.  
 
Here is reported a valuable platform for the downstream processing and monitoring of the in vivo production of 
site-specifically functionalized enveloped Influenza VLPs. This strategy involves a two-step procedure that 
consists of residue-specific replacement of methionine by an analog (azidohomolanine) that enabled for post-
expression functionalization with a fluorophore.[2]  
 
Importantly, this platform does not impact VLP production or purification processes, and allows functionalization 
without deleterious effect on hemagglutinin biological function.  As a proof of concept a complete downstream 
processing was performed, including clarification, capture and polishing steps. A flow cytometry analysis (FACS) 
step was added to achieve a refined discrimination and separation between VLPs and baculovirus - the major 
impurity of the process.[3] This was further confirmed using atomic force microscopy (AFM). This tool allowed to 
accurately monitor our product, achieve higher product recovery yields and higher impurity removal levels. The 
versatile system presented here is broadly applicable to the production of functionalized enveloped VLPs, for 
vaccine design, targeted drug delivery and molecular imaging.  
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